Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, knows this firsthand. In 2016, after AlphaGo—the AI ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
On the heels of releasing its most capable AI model yet, Google is making some changes to the Gemini team. A new report from ...
FREE TO READ] Google’s AI arm led by Demis Hassabis makes it harder for its researchers to publish studies in major change in approach ...